XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Immaterial Error Correction (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2020
Dec. 31, 2020
Concentration Risk [Line Items]                  
Net revenue $ 860,272       $ 740,848 $ 1,619,509 $ 1,446,288    
Commercial payers                  
Concentration Risk [Line Items]                  
Net revenue $ 746,647 $ 648,507 $ 690,686 $ 678,706 642,726 $ 1,395,154 1,248,720 $ 1,927,426 $ 2,618,112
Commercial payers | Revenue Benchmark | Company's Largest Payer                  
Concentration Risk [Line Items]                  
Concentration risk 86.80% 85.40% 85.90% 86.80%   86.10%   86.50% 86.40%
Government payers                  
Concentration Risk [Line Items]                  
Net revenue $ 102,581 $ 97,841 $ 100,431 $ 93,114 $ 95,124 $ 200,422 $ 181,395 $ 274,509 $ 374,940
Government payers | Revenue Benchmark | Company's Largest Payer                  
Concentration Risk [Line Items]                  
Concentration risk 11.90% 12.90% 12.50% 11.90%   12.40%   12.40% 12.30%
Previously Reported | Commercial payers                  
Concentration Risk [Line Items]                  
Net revenue $ 703,429 $ 611,434 $ 649,880 $ 644,385   $ 1,314,862   $ 1,893,105 $ 2,542,985
Previously Reported | Commercial payers | Revenue Benchmark | Company's Largest Payer                  
Concentration Risk [Line Items]                  
Concentration risk 81.80% 80.50% 80.80% 82.40%   81.20%   85.00% 83.90%
Previously Reported | Government payers                  
Concentration Risk [Line Items]                  
Net revenue $ 145,799 $ 134,914 $ 141,237 $ 127,435   $ 280,714   $ 308,830 $ 450,067
Previously Reported | Government payers | Revenue Benchmark | Company's Largest Payer                  
Concentration Risk [Line Items]                  
Concentration risk 16.90% 17.80% 17.60% 16.30%   17.30%   13.90% 14.80%
Revision of Prior Period, Adjustment | Commercial payers                  
Concentration Risk [Line Items]                  
Net revenue $ 43,218 $ 37,073 $ 40,806 $ 34,321   $ 80,292   $ 34,321 $ 75,127
Revision of Prior Period, Adjustment | Commercial payers | Revenue Benchmark | Company's Largest Payer                  
Concentration Risk [Line Items]                  
Concentration risk 5.00% 4.90% 5.10% 4.40%   4.90%   1.50% 2.50%
Revision of Prior Period, Adjustment | Government payers                  
Concentration Risk [Line Items]                  
Net revenue $ (43,218) $ (37,073) $ (40,806) $ (34,321)   $ (80,292)   $ (34,321) $ (75,127)
Revision of Prior Period, Adjustment | Government payers | Revenue Benchmark | Company's Largest Payer                  
Concentration Risk [Line Items]                  
Concentration risk (5.00%) (4.90%) (5.10%) (4.40%)   (4.90%)   (1.50%) (2.50%)